Recent Discoveries & Advances

Recent Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our blog, On Cancer.

Search by keywords:

160 News Items found


MSK Study Examines Cancer-Care Outcomes among US Hospitals

A new study suggests that hospitals’ long-term survival outcomes for cancer patients can be sufficiently assessed without information on tumor stage.


Three Young Investigators Named Winners of 2015 Paul Marks Prize for Cancer Research

These early-career scientists are working on diverse areas of cancer biology including epigenetics, genetic changes that allow metastasis, and genomic integrity.

Paul Marks Prize medal

In the Lab

Researchers Discover How Gene Mutation Leads to Follicular Lymphoma

Research clarifies how abnormalities in a gene called KMT2D contribute to the development of follicular lymphoma, a common but incurable form of non-Hodgkin lymphoma.

A field of lymph nodes connected by multiple lymphatic vessels with one node in cross section showing the pathology of follicular lymphoma breaking through the node capsule.

In the Clinic

Aggressive Lung Adenocarcinoma Subtype May Require New Treatment Strategy

Some early-stage lung adenocarcinoma patients have an aggressive subtype that often returns after surgery, even when tumors are small.

Microscopic image of lung cancer cells

In the Clinic

New Tool Makes It Easier for Patients in Clinical Trials to Report Side Effects

Investigators have been searching for new ways to enable patients to report symptoms they experience during research trials, and to allow researchers to scientifically evaluate those issues.

In the Clinic

Hyperpolarized MRI: A New Tool to Assess Treatment Response within Days

MSK researchers are evaluating a powerful new tool called hyperpolarized MRI, which could allow doctors to get a read on a tumor’s response to treatment quickly.

Hyperpolarized MRI

In the Lab

Therapies that Target mTOR May Enable Some Cancer Cells to Grow

Research into the mTOR pathway is beginning to to explain why some targeted therapies don’t work as well as expected against certain types of cancer.

Cancer biologist Wilhelm Palm


Scientists Link Gene to Inherited Form of Childhood Leukemia

Researchers have found that some cases of acute lymphoblastic leukemia in children may be linked to an inherited gene mutation.

Child hand with IV holding adult hand.

In the Clinic

Experimental Drug Targets Rare Joint Disorder

A new targeted therapy is showing promise in treating tenosynovial giant-cell tumor, a joint disease also known as pigmented villonodular synovitis.

MRI image of a tumor behind the knee.

In the Lab

Discovery Could Boost New Therapies for Myeloproliferative Neoplasms

Researchers have discovered a way to potentially make drugs more effective at treating certain blood cancers.

Illustration of normal blood cells (red discs) along with cancer cells (black spheres) floating through a blood vessel.